Global Clinical Mass Spectrometry Market Insights, Forecast to 2025
Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics.
Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.
The global production of the Clinical Mass Spectrometry is about 1931 units, North America is the largest production region, and the North America occupies about 63% of the market share. The second largest region is Europe, the region occupies about 25% market share, the Asia has little production, it only occupies about 10% market share in 2015. The largest company is Thermo Fisher, it occupies more than 26% of the market share, and the second largest company is AB Sciex (Danaher).
The largest consumption region is North America, it occupies about 46% market share in 2015, the second largest region is the Europe, it occupies about 32% market share, and the smallest consumption region is ROW, the consumption rate in China is about 6% in 2015.
In the last five years, the Clinical Mass Spectrometry has great consumption growth rate, it can be divided into two types LC-MS and GC-MS, the LC-MS occupies about 81% market share in 2015, in the application region, it mainly used in the Clinical Research, it occupies about 74% market share in 2015; In the future, the permeability will have high growth rate, the price have great relationship with the raw material and technology.
The global Clinical Mass Spectrometry market is valued at 640 million US$ in 2018 and will reach 970 million US$ by the end of 2025, growing at a CAGR of 5.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Clinical Mass Spectrometry market based on company, product type, end user and key regions.
This report studies the global market size of Clinical Mass Spectrometry in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Clinical Mass Spectrometry in these regions.
This research report categorizes the global Clinical Mass Spectrometry market by top players/brands, region, type and end user. This report also studies the global Clinical Mass Spectrometry market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Thermo Fisher
AB Sciex (Danaher)
Waters
Agilent
Bruker
Perkin Elmer
Shidmazu
Market size by Product
LC-MS
GC-MS
Market size by End User
Clinical Diagnostics
Clinical Research
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Clinical Mass Spectrometry market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Clinical Mass Spectrometry market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Clinical Mass Spectrometry companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Clinical Mass Spectrometry submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Clinical Mass Spectrometry are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Clinical Mass Spectrometry market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.
The global production of the Clinical Mass Spectrometry is about 1931 units, North America is the largest production region, and the North America occupies about 63% of the market share. The second largest region is Europe, the region occupies about 25% market share, the Asia has little production, it only occupies about 10% market share in 2015. The largest company is Thermo Fisher, it occupies more than 26% of the market share, and the second largest company is AB Sciex (Danaher).
The largest consumption region is North America, it occupies about 46% market share in 2015, the second largest region is the Europe, it occupies about 32% market share, and the smallest consumption region is ROW, the consumption rate in China is about 6% in 2015.
In the last five years, the Clinical Mass Spectrometry has great consumption growth rate, it can be divided into two types LC-MS and GC-MS, the LC-MS occupies about 81% market share in 2015, in the application region, it mainly used in the Clinical Research, it occupies about 74% market share in 2015; In the future, the permeability will have high growth rate, the price have great relationship with the raw material and technology.
The global Clinical Mass Spectrometry market is valued at 640 million US$ in 2018 and will reach 970 million US$ by the end of 2025, growing at a CAGR of 5.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Clinical Mass Spectrometry market based on company, product type, end user and key regions.
This report studies the global market size of Clinical Mass Spectrometry in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Clinical Mass Spectrometry in these regions.
This research report categorizes the global Clinical Mass Spectrometry market by top players/brands, region, type and end user. This report also studies the global Clinical Mass Spectrometry market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Thermo Fisher
AB Sciex (Danaher)
Waters
Agilent
Bruker
Perkin Elmer
Shidmazu
Market size by Product
LC-MS
GC-MS
Market size by End User
Clinical Diagnostics
Clinical Research
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Clinical Mass Spectrometry market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Clinical Mass Spectrometry market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Clinical Mass Spectrometry companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Clinical Mass Spectrometry submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Clinical Mass Spectrometry are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Clinical Mass Spectrometry market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
